<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>FUT2-FUT3 genes &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/fut2-fut3-genes/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Tue, 29 Apr 2025 00:30:54 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>FUT2-FUT3 genes &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Genetic Tool Enhances Treatment Strategies for Pancreatic Cancer</title>
		<link>https://bioengineer.org/genetic-tool-enhances-treatment-strategies-for-pancreatic-cancer/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 29 Apr 2025 00:30:54 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[FUT2-FUT3 genes]]></category>
		<category><![CDATA[Genetic predictive models]]></category>
		<category><![CDATA[Pancreatic cancer treatment]]></category>
		<category><![CDATA[Personalized oncology advancements]]></category>
		<category><![CDATA[Tumor marker normalization]]></category>
		<guid isPermaLink="false">https://bioengineer.org/genetic-tool-enhances-treatment-strategies-for-pancreatic-cancer/</guid>

					<description><![CDATA[Researchers in Japan have unveiled a groundbreaking predictive model that promises to revolutionize the treatment landscape for patients with advanced pancreatic cancer. Pancreatic cancer, infamous for its poor prognosis and limited treatment options, poses significant challenges in clinical management, especially when determining the potential efficacy of surgical interventions following chemoradiotherapy. By integrating the nuances of [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">242524</post-id>	</item>
	</channel>
</rss>
